Jennifer Cheng

Jennifer Cheng

No más puestos en curso

51 años
Health Technology
Consumer Services
Consumer Non-Durables

Origen de la red de primer grado Jennifer Cheng.

EntidadTipo de entidadIndustria
Public Company Pharmaceuticals: Major 40
Extinct Household/Personal Care 9

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Jennifer Cheng a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
Biotechnology

Ian Clark

John McLaughlin

Katherine Bock

Aaron Osborne

Chief Executive Officer

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Rekha Hemrajani

Linda Neuman

Corporate Officer/Principal

Corporate Officer/Principal

EXELIXIS, INC. Pharmaceuticals: Major

Leone Patterson

Rekha Hemrajani

Corporate Officer/Principal

Corporate Officer/Principal

CYMABAY THERAPEUTICS, INC. Biotechnology

Thomas Woiwode

Paul Quinlan

Director/Board Member

General Counsel

Biotechnology

John McLaughlin

Mark Blumenkranz

Founder

Founder

University of Notre Dame College/University

John McLaughlin

Roman Rubio

Undergraduate Degree

Undergraduate Degree

Medical Specialties

John McLaughlin

Mark Blumenkranz

Founder

Founder

TURG POIN Pharmaceuticals: Major

Clarence Machado

Athena Countouriotis

Director/Board Member

Chief Executive Officer

Investment Managers

Mitchell Finer

Jim Scopa

Private Equity Investor

Private Equity Investor

GSK PLC Pharmaceuticals: Major

Eric Carter

Amber Salzman

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

College/University

Mitchell Finer

Mark Lupher

Thomas Chalberg

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Stanford University College/University

Mark Blumenkranz

Thomas Woiwode

Corporate Officer/Principal

Doctorate Degree

College/University

Richard Spivey

Carol Hoang

Corporate Officer/Principal

Doctorate Degree

BLUEBIRD BIO, INC. Biotechnology

Mitchell Finer

Linda Bain

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

University of Cambridge College/University

Eric Carter

Ann Mather

Doctorate Degree

Graduate Degree

Massachusetts Institute of Technology College/University

Angela Thedinga

Elizabeth Alcamo

Graduate Degree

Doctorate Degree

Yale University College/University

Bong Koh

Thomas Leung

Undergraduate Degree

Undergraduate Degree

San Francisco State University College/University

Katherine Bock

Calvin Yu

Undergraduate Degree

Undergraduate Degree

University of California, Berkeley College/University

Mitchell Finer

Thomas Woiwode

Michael W. Fitzgerald

Steven Schwartz

Roman Rubio

Joseph Zwillinger

Phillip Eric Lee

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

The University of California, San Francisco College/University

Bong Koh

Roman Rubio

Doctorate Degree

Doctorate Degree

University of San Francisco College/University

James Shahbazian

Dena House

Undergraduate Degree

Undergraduate Degree

Investment Managers

Thomas Woiwode

Elizabeth Alcamo

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Paul Cleveland

Paul Quinlan

Corporate Officer/Principal

Corporate Officer/Principal

ALDER BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Eric Carter

Paul Cleveland

Chief Tech/Sci/R&D Officer

Chief Executive Officer

NEVRO CORP. Medical Specialties

Jim Scopa

Katherine Bock

Corporate Officer/Principal

Investor Relations Contact

IVERIC BIO, INC. Pharmaceuticals: Generic

Mark Blumenkranz

Steven Schwartz

Director/Board Member

Director/Board Member

Household/Personal Care

Frederic Stoeckel

Corporate Officer/Principal

IOVANCE BIOTHERAPEUTICS, INC. Biotechnology

Athena Countouriotis

Michael Swartzburg

Director/Board Member

Director of Finance/CFO

The Wharton School of the University of Pennsylvania College/University

Roman Rubio

Joseph Zwillinger

Katherine Bock

Masters Business Admin

Masters Business Admin

Masters Business Admin

Stanford University School of Medicine College/University

Mark Blumenkranz

Thomas Chalberg

Corporate Officer/Principal

Doctorate Degree

Harvard Business School College/University

Jim Scopa

Bong Koh

Thomas Leung

Masters Business Admin

Masters Business Admin

Masters Business Admin

Harvard Law School College/University

Clarence Machado

Jim Scopa

Graduate Degree

Graduate Degree

Medical Specialties

Mark Blumenkranz

Steven Schwartz

Director/Board Member

Director/Board Member

Packaged Software

Mark Blumenkranz

Thomas Chalberg

Steven Schwartz

Carol Hoang

Founder

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Medical Specialties

Mitchell Finer

Thomas Woiwode

Elizabeth Alcamo

Founder

Director/Board Member

Corporate Officer/Principal

ARCUS BIOSCIENCES, INC. Biotechnology

Clarence Machado

Rekha Hemrajani

Katherine Bock

Director/Board Member

Director of Finance/CFO

Investor Relations Contact

PASSAGE BIO, INC. Biotechnology

Thomas Woiwode

Athena Countouriotis

Director/Board Member

Director/Board Member

Biotechnology

Mitchell Finer

Jim Scopa

Director/Board Member

Director/Board Member

Solazyme, Inc.

Ian Clark

Joseph Zwillinger

Director/Board Member

Corporate Officer/Principal

ALIGOS THERAPEUTICS, INC. Pharmaceuticals: Major

Jim Scopa

Thomas Woiwode

Director/Board Member

Director/Board Member

4D MOLECULAR THERAPEUTICS, INC. Biotechnology

Phillip Eric Lee

Elizabeth Alcamo

Director/Board Member

Corporate Officer/Principal

NKARTA, INC. Biotechnology

Leone Patterson

Angela Thedinga

Director/Board Member

Director/Board Member

Biotechnology

Amber Salzman

Director/Board Member

Estadísticas

Internacional

Estados Unidos 46
Reino Unido 4
Suiza 2

Sectorial

Health Technology 29
Consumer Services 15
Finance 4
Commercial Services 2
Consumer Non-Durables 2

Operativa

Director/Board Member 228
Corporate Officer/Principal 111
Independent Dir/Board Member 85
Chief Tech/Sci/R&D Officer 49
Undergraduate Degree 40
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA